Quarterly Result7 May 2026, 11:01 pm
Vivanza Biosciences Approves Audited Financial Results for FY26
AI Summary
Vivanza Biosciences Ltd's Board of Directors approved the audited standalone and consolidated financial results as per Indian Accounting Standards (Ind AS) for the quarter and year ended March 31, 2026. The board also took note of the resignations of Mr. Hemant Amrish Parikh as a Non-Executive Director (effective March 17, 2026) and CS Chaitra Arora as Company Secretary & Compliance Officer (effective April 30, 2026). Additionally, the Board approved the reconstitution of various committees, including the Audit Committee.
Key Highlights
- Audited financial results (standalone and consolidated) approved for FY26.
- Hemant Amrish Parikh resigned as Non-Executive Director effective March 17, 2026.
- CS Chaitra Arora resigned as Company Secretary & Compliance Officer effective April 30, 2026.
- Board approved reconstitution of Audit Committee and other committees.
- Shivam Soni & Co. issued an audit opinion on the standalone financial results.
Price Impact
More from VIVANZA